Embecta Corp Stock Today
| EMBC Stock | USD 10.00 0.06 0.60% |
PerformanceWeakest
| Odds Of DistressLow
|
Embecta Corp is trading at 10.00 as of the 12th of February 2026, a 0.6% down since the beginning of the trading day. The stock's open price was 10.06. Embecta Corp has only a 8 % chance of going through financial distress over the next few years, but has generated negative returns over the last 90 days. Note, on April 26, 2022, Representative Tom Cole of US Congress acquired under $15k worth of Embecta Corp's common stock.
Business Domain Health Care Equipment & Services | IPO Date 1st of April 2022 | Category Healthcare | Classification Health Care |
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. operates independently of Becton, Dickinson and Company as of April 1, 2022. Embecta Corp operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. The company has 59.22 M outstanding shares of which 3.87 M shares are currently shorted by private and institutional investors with about 7.05 trading days to cover. More on Embecta Corp
Moving together with Embecta Stock
Moving against Embecta Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Embecta Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO President | Devdatt Kurdikar | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, SP Small-Cap 600, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsBy employing borrowed capital, Embecta Corp can potentially magnify investment returns. Examining the debt-to-assets ratio offers investors perspective on Embecta Corp's use of financial leverage and reveals what portion of Embecta Corp's asset base relies on creditor financing.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Embecta Corp (EMBC) is traded on NASDAQ Exchange in USA and employs 1,850 people. Embecta Corp is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 592.2 M. Embecta Corp conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 59.22 M outstanding shares of which 3.87 M shares are currently shorted by private and institutional investors with about 7.05 trading days to cover.
Embecta Corp currently holds about 292.3 M in cash with 191.7 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.05.
Check Embecta Corp Probability Of Bankruptcy
Ownership AllocationThe majority of Embecta Corp outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Embecta Corp to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Embecta Corp. Please pay attention to any change in the institutional holdings of Embecta Corp as this could imply that something significant has changed or is about to change at the company. On April 26, 2022, Representative Tom Cole of US Congress acquired under $15k worth of Embecta Corp's common stock.
Check Embecta Ownership Details
Embecta Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Morgan Stanley - Brokerage Accounts | 2025-06-30 | 1.2 M | |
| Rubric Capital Management Lp | 2025-06-30 | 1 M | |
| Charles Schwab Investment Management Inc | 2025-06-30 | 886.3 K | |
| Ameriprise Financial Inc | 2025-06-30 | 709.8 K | |
| Dimensional Fund Advisors, Inc. | 2025-06-30 | 708.3 K | |
| Northern Trust Corp | 2025-06-30 | 645.1 K | |
| Bank Of New York Mellon Corp | 2025-06-30 | 635.8 K | |
| D. E. Shaw & Co Lp | 2025-06-30 | 618.8 K | |
| Goldman Sachs Group Inc | 2025-06-30 | 471.4 K | |
| Blackrock Inc | 2025-06-30 | 8.9 M | |
| Vanguard Group Inc | 2025-06-30 | 5.5 M |
Embecta Corp Historical Income Statement
Embecta Stock Against Markets
Embecta Corp Corporate Management
| Pravesh Khandelwal | VP Relations | Profile | |
| Anthony Roth | Chief VP | Profile | |
| Jeffrey Mann | General VP | Profile | |
| Shaun Curtis | Senior Chain | Profile | |
| Ginny Blocki | Senior Management | Profile | |
| Ajay Kumar | VP Officer | Profile | |
| Jean Casner | Senior Officer | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Embecta Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. For information on how to trade Embecta Stock refer to our How to Trade Embecta Stock guide.You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Will Health Care Equipment & Supplies sector continue expanding? Could Embecta diversify its offerings? Factors like these will boost the valuation of Embecta Corp. Projected growth potential of Embecta fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Embecta Corp data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.827 | Dividend Share 0.6 | Earnings Share 2.35 | Revenue Per Share | Quarterly Revenue Growth (0) |
Embecta Corp's market price often diverges from its book value, the accounting figure shown on Embecta's balance sheet. Smart investors calculate Embecta Corp's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Embecta Corp's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Embecta Corp's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Embecta Corp should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Embecta Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.